Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Patient initiated partner treatment for Chlamydia trachomatis infection in the Netherlands: views of patients with and partners notified for Chlamydia.

Nanhoe AC, Watzeels AJCM, Götz HM.

Int J STD AIDS. 2019 Sep 19:956462419851906. doi: 10.1177/0956462419851906. [Epub ahead of print] No abstract available.

PMID:
31533531
2.

Viable Bacterial Load Is Key to Azithromycin Treatment Failure in Rectally Chlamydia trachomatis Infected Women (FemCure).

Dukers-Muijrers NHTM, Wolffs PFG, de Vries HJC, Götz HM, Janssen K, Hoebe CJPA.

J Infect Dis. 2019 Sep 13;220(8):1389-1390. doi: 10.1093/infdis/jiz267. No abstract available.

PMID:
31107956
3.

Treatment effectiveness of azithromycin and doxycycline in uncomplicated rectal and vaginal Chlamydia trachomatis infections in women: a multicentre observational study (FemCure).

Dukers-Muijrers NHTM, Wolffs PFG, Vries H, Götz HM, Heijman T, Bruisten S, Eppings L, Hogewoning A, Steenbakkers M, Lucchesi M, Schim van der Loeff MF, Hoebe CJPA.

Clin Infect Dis. 2019 Jan 28. doi: 10.1093/cid/ciz050. [Epub ahead of print]

PMID:
30689759
5.

Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial.

Hoenderboom BM, van Benthem BHB, van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA, Hogewoning AA, Land JA, van der Sande MAB, Morré SA, van den Broek IVF.

Sex Transm Infect. 2019 Jun;95(4):300-306. doi: 10.1136/sextrans-2018-053778. Epub 2019 Jan 3.

6.

Case series on acute HCV in HIV-negative men in regular clinical practice: a call for action.

Boerekamps A, Wouters K, Ammerlaan HSM, Götz HM, Laga M, Rijnders BJA.

Neth J Med. 2018 Oct;76(8):374-378.

7.

Trends and determinants of antimicrobial susceptibility of Neisseria gonorrhoeae in the Netherlands, 2007 to 2015.

Hofstraat SH, Götz HM, van Dam AP, van der Sande MA, van Benthem BH.

Euro Surveill. 2018 Sep;23(36). doi: 10.2807/1560-7917.ES.2018.23.36.1700565.

8.

[Chlamydia: a pill for the partner? Results of the PICC-UP project on patient-initiated partner therapy].

Götz HM, van Bergen JEAM, Philips-Santman C, van Benthem BHB.

Ned Tijdschr Geneeskd. 2018 May 18;162. pii: D2703. Dutch.

PMID:
30040313
9.

A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands.

Nanhoe AC, Visser M, Omlo JJ, Watzeels AJCM, van den Broek IV, Götz HM.

BMC Infect Dis. 2018 May 29;18(1):243. doi: 10.1186/s12879-018-3139-0.

10.

Acute hepatitis C in HIV-negative men who have sex with men in the Netherlands and Belgium: a call for action.

Boerekamps A, Wouters K, Ammerlaan HSM, Götz HM, Laga M, Rijnders BJA.

Sex Transm Infect. 2018 Jun;94(4):297. doi: 10.1136/sextrans-2018-053526. No abstract available.

PMID:
29777055
11.

STIs in sex partners notified for chlamydia exposure: implications for expedited partner therapy.

van Aar F, van Benthem BHB, van den Broek IVF, Götz HM.

Sex Transm Infect. 2018 Dec;94(8):619-621. doi: 10.1136/sextrans-2017-053364. Epub 2018 Jan 11.

PMID:
29326177
12.

Partner notification and partner treatment for chlamydia: attitude and practice of general practitioners in the Netherlands; a landscape analysis.

van den Broek IVF, Donker GA, Hek K, van Bergen JEAM, van Benthem BHB, Götz HM.

BMC Fam Pract. 2017 Dec 20;18(1):103. doi: 10.1186/s12875-017-0676-3.

13.

Consequences of restricted STI testing for young heterosexuals in the Netherlands on test costs and QALY losses.

Suijkerbuijk AWM, Over EAB, van Aar F, Götz HM, van Benthem BHB, Lugnér AK.

Health Policy. 2018 Feb;122(2):198-203. doi: 10.1016/j.healthpol.2017.12.001. Epub 2017 Dec 8.

PMID:
29246657
14.

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Hoenderboom BM, van Oeffelen AA, van Benthem BH, van Bergen JE, Dukers-Muijrers NH, Götz HM, Hoebe CJ, Hogewoning AA, van der Klis FR, van Baarle D, Land JA, van der Sande MA, van Veen MG, de Vries F, Morré SA, van den Broek IV.

BMC Infect Dis. 2017 Apr 11;17(1):264. doi: 10.1186/s12879-017-2376-y.

15.

Ethnic and regional differences in STI clinic use: a Dutch epidemiological study using aggregated STI clinic data combined with population numbers.

van Oeffelen AA, van den Broek IV, Doesburg M, Boogmans B, Götz HM, van Leeuwen-Voerman FA, van Veen MG, Woestenberg PJ, van Benthem BH, van Steenbergen JE.

Sex Transm Infect. 2017 Feb;93(1):46-51. doi: 10.1136/sextrans-2016-052558. Epub 2016 Jun 28.

PMID:
27606682
16.

Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.

Xiridou M, Lugnér A, de Vries HJ, van Bergen JE, Götz HM, van Benthem BH, Wallinga J, van der Sande MA.

Sex Transm Dis. 2016 Sep;43(9):542-8. doi: 10.1097/OLQ.0000000000000480.

PMID:
27513379
17.

Design of the FemCure study: prospective multicentre study on the transmission of genital and extra-genital Chlamydia trachomatis infections in women receiving routine care.

Dukers-Muijrers NH, Wolffs PF, Eppings L, Götz HM, Bruisten SM, Schim van der Loeff MF, Janssen K, Lucchesi M, Heijman T, van Benthem BH, van Bergen JE, Morre SA, Herbergs J, Kok G, Steenbakkers M, Hogewoning AA, de Vries HJ, Hoebe CJ.

BMC Infect Dis. 2016 Aug 8;16:381. doi: 10.1186/s12879-016-1721-x.

18.

Prediction of Chlamydia trachomatis infection to facilitate selective screening on population and individual level: a cross-sectional study of a population-based screening programme.

van Klaveren D, Götz HM, Op de Coul EL, Steyerberg EW, Vergouwe Y.

Sex Transm Infect. 2016 Sep;92(6):433-40. doi: 10.1136/sextrans-2015-052048. Epub 2016 Feb 3.

PMID:
26843401
19.

Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study.

Nichols BE, Götz HM, van Gorp EC, Verbon A, Rokx C, Boucher CA, van de Vijver DA.

PLoS One. 2015 Nov 10;10(11):e0142576. doi: 10.1371/journal.pone.0142576. eCollection 2015.

20.

Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey.

van den Broek IV, Sfetcu O, van der Sande MA, Andersen B, Herrmann B, Ward H, Götz HM, Uusküla A, Woodhall SC, Redmond SM, Amato-Gauci AJ, Low N, van Bergen JE.

Eur J Public Health. 2016 Jun;26(3):382-8. doi: 10.1093/eurpub/ckv196. Epub 2015 Oct 24.

21.

Sexually transmitted infections among female sex workers tested at STI clinics in the Netherlands, 2006-2013.

Verscheijden MMA, Woestenberg PJ, Götz HM, van Veen MG, Koedijk FDH, van Benthem BHB.

Emerg Themes Epidemiol. 2015 Aug 28;12:12. doi: 10.1186/s12982-015-0034-7. eCollection 2015.

22.

Delayed linkage to care in one-third of HIV-positive individuals in the Netherlands.

van Veen MG, Trienekens SC, Heijman T, Gotz HM, Zaheri S, Ladbury G, de Wit J, Fennema JS, de Wolf F, van der Sande MA.

Sex Transm Infect. 2015 Dec;91(8):603-9. doi: 10.1136/sextrans-2014-051980. Epub 2015 May 11.

PMID:
25964506
23.

Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis.

Redmond SM, Alexander-Kisslig K, Woodhall SC, van den Broek IV, van Bergen J, Ward H, Uusküla A, Herrmann B, Andersen B, Götz HM, Sfetcu O, Low N.

PLoS One. 2015 Jan 23;10(1):e0115753. doi: 10.1371/journal.pone.0115753. eCollection 2015. Review.

24.

The added value of chlamydia screening between 2008-2010 in reaching young people in addition to chlamydia testing in regular care; an observational study.

van Liere GA, Dukers-Muijrers NH, van Bergen JE, Götz HM, Stals F, Hoebe CJ.

BMC Infect Dis. 2014 Nov 18;14:612. doi: 10.1186/s12879-014-0612-2.

25.

Use of prediction rules in control of sexually transmitted infections: challenges and chances.

Götz HM, van Klaveren D.

Sex Transm Dis. 2014 May;41(5):331-2. doi: 10.1097/OLQ.0000000000000128. No abstract available.

PMID:
24722389
26.

Initial evaluation of use of an online partner notification tool for STI, called 'suggest a test': a cross sectional pilot study.

Götz HM, van Rooijen MS, Vriens P, Op de Coul E, Hamers M, Heijman T, van den Heuvel F, Koekenbier R, van Leeuwen AP, Voeten HA.

Sex Transm Infect. 2014 May;90(3):195-200. doi: 10.1136/sextrans-2013-051254. Epub 2014 Jan 3. Erratum in: Sex Transm Infect. 2015 Feb;91(1):74.

PMID:
24391062
27.

Use of Chlamydia trachomatis high-resolution typing: an extended case study to distinguish recurrent or persistent infection from new infection.

Götz HM, Bom RJ, Wolfers ME, Fennema J, van den Broek IV, Speksnijder AG, Bruisten SM.

Sex Transm Infect. 2014 Mar;90(2):155-60. doi: 10.1136/sextrans-2013-051218. Epub 2013 Nov 14.

PMID:
24234071
28.
29.

Retesting for genital Chlamydia trachomatis among visitors of a sexually transmitted infections clinic: randomized intervention trial of home- versus clinic-based recall.

Götz HM, Wolfers ME, Luijendijk A, van den Broek IV.

BMC Infect Dis. 2013 May 24;13:239. doi: 10.1186/1471-2334-13-239.

30.

Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates.

Schmid BV, Over EA, van den Broek IV, Op de Coul EL, van Bergen JE, Fennema JS, Götz HM, Hoebe CJ, de Wit GA, van der Sande MA, Kretzschmar ME.

PLoS One. 2013;8(3):e58674. doi: 10.1371/journal.pone.0058674. Epub 2013 Mar 20.

31.

Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation.

van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Götz HM, Hoebe CJ, Koekenbier RH, Kretzschmar M, Over EA, Schmid BV, Pars LL, van Ravesteijn SM, van der Sande MA, de Wit GA, Low N, Op de Coul EL.

BMJ. 2012 Jul 5;345:e4316. doi: 10.1136/bmj.e4316.

32.

High yield of reinfections by home-based automatic rescreening of Chlamydia positives in a large-scale register-based screening programme and determinants of repeat infections.

Götz HM, van den Broek IV, Hoebe CJ, Brouwers EE, Pars LL, Fennema JS, Koekenbier RH, van Ravesteijn S, Op de Coul EL, van Bergen J.

Sex Transm Infect. 2013 Feb;89(1):63-9. doi: 10.1136/sextrans-2011-050455. Epub 2012 Jun 23.

PMID:
22728910
33.

Keeping participants on board: increasing uptake by automated respondent reminders in an Internet-based chlamydia screening in the Netherlands.

Dokkum NF, Koekenbier RH, van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Götz HM, Hoebe CJ, Pars LL, van Ravesteijn SM, Op de Coul EL.

BMC Public Health. 2012 Mar 9;12:176. doi: 10.1186/1471-2458-12-176.

34.

Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity.

Op de Coul EL, Götz HM, van Bergen JE, Fennema JS, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van der Sande MA, van den Broek IV.

Sex Transm Dis. 2012 Feb;39(2):97-103. doi: 10.1097/OLQ.0b013e3182383097.

PMID:
22249297
35.

Systematic selection of screening participants by risk score in a Chlamydia screening programme is feasible and effective.

van den Broek IV, Brouwers EE, Götz HM, van Bergen JE, Op de Coul EL, Fennema JS, Koekenbier RH, Pars LL, van Ravesteijn SM, Hoebe CJ.

Sex Transm Infect. 2012 Apr;88(3):205-11. doi: 10.1136/sextrans-2011-050219. Epub 2012 Jan 3.

PMID:
22215696
36.

Comparing two definitions of ethnicity for identifying young persons at risk for chlamydia.

Haasnoot A, Koedijk FD, Op De Coul EL, Götz HM, van der Sande MA, Van Den Broek IV; CSI Group.

Epidemiol Infect. 2012 May;140(5):951-8. doi: 10.1017/S0950268811001336. Epub 2011 Jul 18.

PMID:
21767454
37.

Acceptability of the internet-based Chlamydia screening implementation in the Netherlands and insights into nonresponse.

Greenland KE, Op de Coul EL, van Bergen JE, Brouwers EE, Fennema HJ, Götz HM, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van den Broek IV.

Sex Transm Dis. 2011 Jun;38(6):467-74. doi: 10.1097/OLQ.0b013e318204546e.

PMID:
21217416
38.

Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands.

van Bergen JE, Fennema JS, van den Broek IV, Brouwers EE, de Feijter EM, Hoebe CJ, Koekenbier RH, de Coul EL, van Ravesteijn SM, Götz HM.

BMC Infect Dis. 2010 Oct 7;10:293. doi: 10.1186/1471-2334-10-293.

39.
40.

Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis.

van den Broek IV, Hoebe CJ, van Bergen JE, Brouwers EE, de Feijter EM, Fennema JS, Götz HM, Koekenbier RH, van Ravesteijn SM, de Coul EL.

BMC Infect Dis. 2010 Apr 7;10:89. doi: 10.1186/1471-2334-10-89.

41.

An improved approach to identify epidemiological and phylogenetic transmission pairs of source and contact tracing of hepatitis B.

Veldhuijzen IK, Mes TH, Mostert MC, Niesters HG, Pas SD, Voermans J, de Man RA, Götz HM, van Doornum GJ, Richardus JH.

J Med Virol. 2009 Mar;81(3):425-34. doi: 10.1002/jmv.21413.

PMID:
19152416
42.

HIV and sexual risk behavior among commercial sex workers in the Netherlands.

van Veen MG, Götz HM, van Leeuwen PA, Prins M, van de Laar MJ.

Arch Sex Behav. 2010 Jun;39(3):714-23. doi: 10.1007/s10508-008-9396-z. Epub 2008 Sep 25.

PMID:
18815876
43.

A cluster of hepatitis B infections associated with incorrect use of a capillary blood sampling device in a nursing home in the Netherlands, 2007.

Götz HM, Schutten M, Borsboom GJ, Hendriks B, van Doornum G, de Zwart O.

Euro Surveill. 2008 Jul 3;13(27). pii: 18918.

44.

Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups.

Koene RP, Gotz HM, Van Den Hoek JA, Heijnen ML, Van Steenbergen JA, Kroes AC.

Epidemiol Infect. 2009 Apr;137(4):495-503. doi: 10.1017/S095026880800085X. Epub 2008 Jul 23.

PMID:
18647436
45.

[The molecular epidemiology of hepatitis A in The Netherlands; the usefulness of typing isolated viral strains].

Bruisten SM, Tjon GM, van den Hoek JA, Wijkmans CJ, Götz HM, Coutinho RA.

Ned Tijdschr Geneeskd. 2007 Dec 15;151(50):2779-86. Dutch.

PMID:
18232198
46.

Lessons learned from a population-based chlamydia screening pilot.

Götz HM, van Bergen JE, Veldhuijzen IK, Hoebe CJ, Broer J, Coenen AJ, de Groot F, Verhooren MJ, van Schaik DT, Richardus JH.

Int J STD AIDS. 2006 Dec;17(12):826-30.

PMID:
17212860
47.

Risk selection and targeted interventions in community-based control of chlamydia.

Richardus JH, Götz HM.

Curr Opin Infect Dis. 2007 Feb;20(1):60-5. Review.

PMID:
17197883
49.

A slow epidemic of LGV in the Netherlands in 2004 and 2005.

van de Laar MJ, Koedijk FD, Gotz HM, de Vries HJ.

Euro Surveill. 2006 Sep;11(9):150-2.

PMID:
17075162
50.

Chlamydia trachomatis infections in multi-ethnic urban youth: a pilot combining STI health education and outreach testing in Rotterdam, Netherlands.

Götz HM, Veldhuijzen IK, Ossewaarde JM, de Zwart O, Richardus JH.

Sex Transm Infect. 2006 Apr;82(2):148-52; discussion 152-3.

Supplemental Content

Support Center